139 related articles for article (PubMed ID: 14527109)
1. A case study on rheumatoid arthritis.
Baker T
Am J Manag Care; 2003 Sep; 9(4 Suppl):S87-98. PubMed ID: 14527109
[TBL] [Abstract][Full Text] [Related]
2. Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population.
Ollendorf DA; Peterson AN; Doyle J; Huse DM
Am J Manag Care; 2002 May; 8(7 Suppl):S203-13. PubMed ID: 12022236
[TBL] [Abstract][Full Text] [Related]
3. Coverage inequalities of new therapies for rheumatoid arthritis in a managed care setting.
Gallup E
Manag Care Interface; 2001 Jul; 14(7):52-4, 57-8, 69. PubMed ID: 11481817
[TBL] [Abstract][Full Text] [Related]
4. Medicare coverage of tumor necrosis factor alpha inhibitors as an influence on physicians' prescribing behavior.
DeWitt EM; Glick HA; Albert DA; Joffe MM; Wolfe F
Arch Intern Med; 2006 Jan; 166(1):57-63. PubMed ID: 16401811
[TBL] [Abstract][Full Text] [Related]
5. Etanercept or infliximab: the patient's considerations.
Sherrick RC
Arch Intern Med; 2006 Jul; 166(13):1418; author reply 1418. PubMed ID: 16832010
[No Abstract] [Full Text] [Related]
6. Anti-tumour necrosis factor therapy in the West Midlands.
Bartram D; Sheeran T; Price T; Mulherin D
Rheumatology (Oxford); 2004 Mar; 43(3):400; author reply 400-1. PubMed ID: 14963219
[No Abstract] [Full Text] [Related]
7. Etanercept and its implications for managed care.
Lipsy RJ
Am J Manag Care; 2002 Apr; 8(6 Suppl):S194-200. PubMed ID: 11990864
[TBL] [Abstract][Full Text] [Related]
8. [Anti-rheumatoid biologics and pharmacoeconomic evaluation].
Tsutani K; Igarashi A
Nihon Rinsho; 2005 Jan; 63 Suppl 1():711-8. PubMed ID: 15799447
[No Abstract] [Full Text] [Related]
9. Maintaining and optimising anti-TNF therapy.
Somerville M
Musculoskeletal Care; 2007 Dec; 5 Suppl 1():1-17. PubMed ID: 18050263
[No Abstract] [Full Text] [Related]
10. Successful etanercept use in an HIV-positive patient with rheumatoid arthritis.
Kaur PP; Chan VC; Berney SN
J Clin Rheumatol; 2007 Apr; 13(2):79-80. PubMed ID: 17414534
[TBL] [Abstract][Full Text] [Related]
11. Do rheumatology cost-effectiveness analyses make sense?
Wolfe F; Michaud K; Pincus T
Rheumatology (Oxford); 2004 Jan; 43(1):4-6. PubMed ID: 14523227
[No Abstract] [Full Text] [Related]
12. The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.
Cohen SB
Rheum Dis Clin North Am; 2004 May; 30(2):365-80, vii. PubMed ID: 15172046
[TBL] [Abstract][Full Text] [Related]
13. Back to the future: the managed care approach to rheumatoid arthritis.
Sidorov J
Manag Care Interface; 2007 Jul; 20(7):28-30. PubMed ID: 17849731
[TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.
Bliddal H; Terslev L; Qvistgaard E; Konig M; Holm CC; Rogind H; Boesen M; Danneskiold-Samsøe B; Torp-Pedersen S
Scand J Rheumatol; 2006; 35(5):341-5. PubMed ID: 17062431
[TBL] [Abstract][Full Text] [Related]
15. Effective coverage and reimbursement strategies for etanercept and infliximab in the treatment of rheumatoid arthritis.
Sokol MC
Manag Care Interface; 2005 Apr; 18(4):32-7. PubMed ID: 15889761
[TBL] [Abstract][Full Text] [Related]
16. Complex treatment options for rheumatoid arthritis.
Giaquinta D
Manag Care Interface; 2001 Jul; 14(7):49-51. PubMed ID: 11481816
[No Abstract] [Full Text] [Related]
17. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
[No Abstract] [Full Text] [Related]
18. Two is better than one? Combination therapy in rheumatoid arthritis.
Choy EH
Rheumatology (Oxford); 2004 Oct; 43(10):1205-7. PubMed ID: 15226519
[No Abstract] [Full Text] [Related]
19. Treatment of rheumatoid arthritis with etanercept.
Genovese MC; Kremer JM
Rheum Dis Clin North Am; 2004 May; 30(2):311-28, vi-vii. PubMed ID: 15172043
[TBL] [Abstract][Full Text] [Related]
20. Do etanercept-naive patients with rheumatoid arthritis respond better to infliximab than patients for whom etanercept has failed?
Yazici Y; Erkan D
Ann Rheum Dis; 2004 May; 63(5):607-8; author reply 608. PubMed ID: 15082503
[No Abstract] [Full Text] [Related]
[Next] [New Search]
